Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoni Riera-Mestre

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|September 28, 2018
Diagnosis and Management of the Antiphospholipid SyndromeAntoni Riera-Mestre, Antonio Vidaller
Revista Espanola De Geriatria Y Gerontologia|January 27, 2015
[Role of acetylsalicylic acid for preventing recurrent venous thromboembolism]Antoni Riera-Mestre, Francesc Formiga
European Journal of Internal Medicine|July 11, 2024
Pioneering the future: CRISPR-Cas9 gene therapy for hereditary hemorrhagic telangiectasia. Author's replyPau Cerdà, Cinthia Aguilera, Antoni Riera-Mestre
Medicina Clinica|July 20, 2023
Hereditary hemorrhagic telangiectasia relapse in liver allograftAntoni Riera-Mestre, Pau Cerdà, Laura Lladó
Medicina Clinica|January 19, 2025
Scurvy: A call to maintain awarenessAntoni Riera-Mestre, Olga Portolà, Antonio Vidaller
Medicina Clinica|December 4, 2018
Medical management of haemorrhagic hereditary telangiectasia in adult patientsAntoni Riera-Mestre, Jesús Ribas, José Castellote
Frontiers in Medicine|July 13, 2023
Editorial: Vascular malformations and thrombosisPierpaolo Di Micco, Antoni Riera-Mestre, Egidio Imbalzano
Vascular Biology (Bristol, England)|March 30, 2022
Rethinking growth factors: the case of BMP9 during vessel maturationFerran Medina-Jover, Antoni Riera-Mestre, Francesc Viñals
Thrombosis Research|December 3, 2014
Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: a meta-analysisAntoni Riera-Mestre, Cecilia Becattini, Michela Giustozzi, et al.
Medicina Clinica|July 20, 2021
[PIK3CA-related overgrowth spectrum (PROS): new insight in known diseases]Adriana Iriarte Fuster, Pau Cerdà Serra, Antoni Riera-Mestre
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|September 28, 2018
Diagnosis and Management of the Antiphospholipid SyndromeAntoni Riera-Mestre, Antonio Vidaller
Revista Espanola De Geriatria Y Gerontologia|January 27, 2015
[Role of acetylsalicylic acid for preventing recurrent venous thromboembolism]Antoni Riera-Mestre, Francesc Formiga
European Journal of Internal Medicine|July 11, 2024
Pioneering the future: CRISPR-Cas9 gene therapy for hereditary hemorrhagic telangiectasia. Author's replyPau Cerdà, Cinthia Aguilera, Antoni Riera-Mestre
Medicina Clinica|July 20, 2023
Hereditary hemorrhagic telangiectasia relapse in liver allograftAntoni Riera-Mestre, Pau Cerdà, Laura Lladó
Medicina Clinica|January 19, 2025
Scurvy: A call to maintain awarenessAntoni Riera-Mestre, Olga Portolà, Antonio Vidaller
Medicina Clinica|December 4, 2018
Medical management of haemorrhagic hereditary telangiectasia in adult patientsAntoni Riera-Mestre, Jesús Ribas, José Castellote
Frontiers in Medicine|July 13, 2023
Editorial: Vascular malformations and thrombosisPierpaolo Di Micco, Antoni Riera-Mestre, Egidio Imbalzano
Vascular Biology (Bristol, England)|March 30, 2022
Rethinking growth factors: the case of BMP9 during vessel maturationFerran Medina-Jover, Antoni Riera-Mestre, Francesc Viñals
Thrombosis Research|December 3, 2014
Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: a meta-analysisAntoni Riera-Mestre, Cecilia Becattini, Michela Giustozzi, et al.
Medicina Clinica|July 20, 2021
[PIK3CA-related overgrowth spectrum (PROS): new insight in known diseases]Adriana Iriarte Fuster, Pau Cerdà Serra, Antoni Riera-Mestre
Pageof 9